Skip to content
Clinical ResearchResearch compoundModerate evidence

Oxiracetam

Stimulating, focus-oriented nootropic from the racetam family; only a few small studies have been done in humans.

NootropicRacetamMemoryFocusAcetylcholineGlutamate

Pharmacology

ClassRacetam · Memory · Focus
Primary targetAMPA receptor (positive allosteric modulation)
Targets4 receptor targets
EvidenceModerate evidence
Affected systemsAcetylcholineGlutamate

Contents

DETAILED OVERVIEW

What is Oxiracetam?

Oxiracetam is a derivative of a compound called piracetam and belongs to the nootropics, substances meant to improve brain performance. In Italy it is known as a prescription medicine; it is not approved in the United States, where it is sold as a research chemical.

It strengthens excitatory signalling between nerve cells and boosts the production of acetylcholine, a chemical messenger. Only a few small studies have been done in humans so far; they described better attention, reaction time and memory, and in rodents modelling dementia it reversed thinking problems. It can cause headache, insomnia, irritability and mild stomach upset. It leaves the body mainly unchanged through the kidneys, so it calls for extra caution in severe kidney damage; in epilepsy and a tendency to seizures, caution is also needed because of its stimulating action. There are not enough safety data for pregnancy and breastfeeding.

Mechanism

Strengthens the AMPA receptor; more acetylcholine is made

Half-life

~8 h

Legal status

EU Rx (IT)

Receptor profile

  • AMPA glutamate receptorModerate
  • Acetylcholine release (HACU)Moderate
  • Phospholipid metabolismModerate
  • Dopamine (prefrontal)Weak

Safety

Side effects, stop signs, contraindications

Side effects · 6

  • Headache from acetylcholine depletion, mitigated by a choline source (Alpha-GPC, CDP-choline)
  • Insomnia and restlessness, especially with late-evening dosing (stimulating-type racetam)
  • Irritability and nervousness at higher doses
  • Mild gastrointestinal discomfort, nausea
  • Mental fatigue or brain fog with insufficient choline intake
  • Dizziness, occasionally brief concentration fluctuations during the initial phase

Contraindications · 5

  • Pregnancy and breastfeeding: insufficient safety data, avoid
  • Severe renal impairment: dose reduction needed, as it is excreted largely unchanged via the kidneys
  • Epilepsy or seizure predisposition: caution due to glutamatergic/AMPA-enhancing activity
  • Concurrent cholinergic agents: combined with a choline source, cholinergic excess (nausea, sweating) may appear instead of headache
  • Stimulants and caffeine: the stimulating effect can stack, increasing anxiety and insomnia

Related Nootropics

Same therapeutic category

FAQ

FAQ

Oxiracetam is a nootropic compound typically used to support focus, concentration and mental alertness, with a somewhat more energizing, stimulant-like feel than some of its more relaxing relatives. According to the description, it works by stimulating brain signaling and the cholinergic system, aiming to sharpen attention and thinking. The available source does not list detailed specific user benefits, so only general statements can be made here.

Telegram

Have a question about Oxiracetam?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

Structure & chemistry

TypeNootropic
FormulaC6H10N2O3
UpdatedOctober 14, 2026
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 14, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.